FDA Announces Voluntary Withdrawal of Pergolide Products
The U.S. Food and Drug Administration (FDA) today announced that manufacturers of pergolide
drug products, which are used to treat Parkinson’s disease, will voluntarily remove// these drugs from the market because of the risk of serious damage to patients’ heart valves.
The products being wit...
Parkinson's Drugs Could Increase Heart Disease Risk
...igher among pergolide-treated patients and five times higher among patients being treated with cabergoline.
"We showed that treatment with either pergolide
or cabergoline for more than six months was strongly associated with an increase in valve-related heart disease," researcher Edeltraut Garbe said.
Pergolide - Wikipedia, the free encyclopediaPergolide
(Permax) is an ergoline-based dopamine receptor agonist used for the treatment of Parkinson's disease.
Pergolide Official FDA information, side effects and uses.
Accurate, FDA approved Pergolide
information for healthcare professionals and patients - brought ... Pergolide
mesylate is provided for oral administration in ...
Pergolide Side Effects | Drugs.com
Comprehensive and accurate Pergolide
side effects information for consumers and healthcare professionals. ... side effects for Pergolide
may not be reported. ...
Permax (Pergolide Mesylate) Drug Information: Uses, Side Effects, Drug ...
Learn about the prescription medication Permax (Pergolide
Mesylate), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
Pergolide, Permax For Veterinary UsePergolide
is the drug of choice for the treatment of pituitary pars intermedia hyperplasia or Equine Cushing's Syndrome (ECS) in horses.
Island Pharmacy Services, Inc. - Pergolide
IPS compounds pergolide
in oral solutions or powder doses. ... Pergolide
: the Drug of Choice for Treating Equine Cushing's Syndrome " ...